BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2026 8:57:26 AM | Browse: 3 | Download: 4
 |
Received |
|
2026-05-19 07:28 |
|
Peer-Review Started |
|
2026-05-19 07:30 |
|
First Decision by Editorial Office Director |
|
2026-05-26 05:58 |
|
Return for Revision |
|
2026-06-25 03:11 |
|
Revised |
|
2026-07-21 15:06 |
|
Publication Fee Transferred |
|
2026-08-01 08:45 |
|
Second Decision by Editor |
|
2026-08-20 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-08-20 08:43 |
|
Articles in Press |
|
2026-08-20 08:43 |
|
Edit the Manuscript by Language Editor |
|
2026-08-25 12:14 |
|
Typeset the Manuscript |
|
2026-09-14 06:52 |
|
Publish the Manuscript Online |
|
2026-09-23 08:57 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Efficacy of transcatheter arterial embolization plus targeted chemotherapy for advanced hepatocellular carcinoma: A case report and literature review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Si-Lei Yu, Jin-E Liu, Chun-Ying Li, Hao Ling, Hai-Yun Tao and Yong-Qi Shen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Liuzhou Municipal Bureau of Science and Technology: Clinical Study of TAE Sequential Anlotinib Combined with Oxaliplatin plus Raltitrexed in the Treatment of Advanced Hepatocellular Carcinoma |
2019BJ10613 |
|
| Corresponding Author |
Yong-Qi Shen, Chief Physician, MD, Department of Oncology, Liutie Central Hospital, No. 14 Limin Community, Fei'e Road, Liunan District, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China. gxnnsyq@163.con |
| Key Words |
Hepatocellular carcinoma; Transcatheter arterial embolization; Oxaliplatin; Raltitrexed; Anlotinib; Case report |
| Core Tip |
This case reports a 52 year old patient diagnosed with hepatocellular carcinoma (CNLC stage IIIB) complicated by active clonorchiasis—an immunotherapy contraindication. The patient received transcatheter arterial embolization followed by sequential oxaliplatin, raltitrexed, and anlotinib, achieving partial response and progression free survival exceeding 50 months. The regimen may offer a viable alternative for immunotherapy ineligible advanced hepatocellular carcinoma patients, though long term efficacy requires further validation. |
| Publish Date |
2026-09-23 08:57 |
| Citation |
Yu SL, Liu JE, Li CY, Ling H, Tao HY, Shen YQ. Efficacy of transcatheter arterial embolization plus targeted chemotherapy for advanced hepatocellular carcinoma: A case report and literature review. World J Clin Oncol 2026; 17(9): 123454
|
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i9/123454.htm |
| DOI |
https://doi.org/10.5306/wjco.123454 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
